Crossmark

Quantifying Return on Investment of Differentiating Technologies in Drug Development: A Decision Analytics Framework

Published Online: 2026-04-23

Published Print: 2026-10

Authors

Nolan, Ryan P.

Theuer, Charles
License Information

Text and Data Mining valid from 2026-04-23

Version of Record valid from 2026-04-23
More Information

Article History

Received: 29 January 2026

Accepted: 28 March 2026

First Online: 23 April 2026

Declarations

:

: R.P.N. and C.T. are employees of Halozyme Therapeutics, Inc. R.P.N. and C.T. are shareholders of Halozyme Therapeutics, Inc.

Document is current